Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jul 2019. Module: SNOMED CT core module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3769531015 | Varicella-zoster virus antibody 500 mg powder for solution for injection vial | en | Synonym | Active | Entire term case sensitive | SNOMED CT core module |
| 3769532010 | Product containing precisely Varicella-zoster virus antibody 500 milligram/1 vial powder for conventional release solution for injection (clinical drug) | en | Fully specified name | Active | Only initial character case insensitive | SNOMED CT core module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing precisely Varicella-zoster virus antibody 500 milligram/1 vial powder for conventional release solution for injection (clinical drug) | Is a | Product containing Varicella-zoster virus antibody (medicinal product) | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely Varicella-zoster virus antibody 500 milligram/1 vial powder for conventional release solution for injection (clinical drug) | Has active ingredient | Antiserum | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely Varicella-zoster virus antibody 500 milligram/1 vial powder for conventional release solution for injection (clinical drug) | Has active ingredient | Immunoglobulin | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely Varicella-zoster virus antibody 500 milligram/1 vial powder for conventional release solution for injection (clinical drug) | Has manufactured dose form | Injection | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely Varicella-zoster virus antibody 500 milligram/1 vial powder for conventional release solution for injection (clinical drug) | Has active ingredient | Varicella-zoster virus antibody | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely Varicella-zoster virus antibody 500 milligram/1 vial powder for conventional release solution for injection (clinical drug) | Is a | Product manufactured as parenteral dose form | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely Varicella-zoster virus antibody 500 milligram/1 vial powder for conventional release solution for injection (clinical drug) | Has manufactured dose form | Powder for conventional release solution for injection | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely Varicella-zoster virus antibody 500 milligram/1 vial powder for conventional release solution for injection (clinical drug) | Is a | TEMPORARY parent for CDs that are not updated | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely Varicella-zoster virus antibody 500 milligram/1 vial powder for conventional release solution for injection (clinical drug) | Has presentation strength denominator unit | Vial | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely Varicella-zoster virus antibody 500 milligram/1 vial powder for conventional release solution for injection (clinical drug) | Has unit of presentation | Vial | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely Varicella-zoster virus antibody 500 milligram/1 vial powder for conventional release solution for injection (clinical drug) | Has presentation strength numerator unit | milligram | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely Varicella-zoster virus antibody 500 milligram/1 vial powder for conventional release solution for injection (clinical drug) | Has presentation strength denominator value | 1 | false | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely Varicella-zoster virus antibody 500 milligram/1 vial powder for conventional release solution for injection (clinical drug) | Has precise active ingredient | Varicella-zoster virus antibody | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely Varicella-zoster virus antibody 500 milligram/1 vial powder for conventional release solution for injection (clinical drug) | Has basis of strength substance | Varicella-zoster virus antibody | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely Varicella-zoster virus antibody 500 milligram/1 vial powder for conventional release solution for injection (clinical drug) | Has presentation strength numerator value | 500 | false | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely Varicella-zoster virus antibody 500 milligram/1 vial powder for conventional release solution for injection (clinical drug) | Count of base of active ingredient | 1 | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely Varicella-zoster virus antibody 500 milligram/1 vial powder for conventional release solution for injection (clinical drug) | Is a | Product containing only Varicella-zoster virus antibody in parenteral dose form (medicinal product form) | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely Varicella-zoster virus antibody 500 milligram/1 vial powder for conventional release solution for injection (clinical drug) | Plays role | Passive immunity stimulant therapeutic role | true | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Varicella-zoster immunoglobulin 500mg injection - product | Is a | False | Product containing precisely Varicella-zoster virus antibody 500 milligram/1 vial powder for conventional release solution for injection (clinical drug) | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets
FHIR